期刊文献+

复方金钱草颗粒临床应用专家共识

Expert Consensus on Clinical Application of Compound Jinqiancao Granules(复方金钱草颗粒)
下载PDF
导出
摘要 复方金钱草颗粒为国家医保目录乙类中成药,在临床上广泛应用于泌尿系结石和尿路感染,经过长期的临床治疗经验,基于问卷调查、专家访谈及研究文献系统分析的基础上,认为复方金钱草颗粒对泌尿系结石和尿路感染疾病有良好的临床疗效,为指南推荐用药。本共识严格遵循中成药临床应用专家共识步骤进行研制,针对泌尿系结石和尿路感染的治疗而制定;采用调查问卷的形式,调查有临床经验的医生,通过对循证医学证据进行综合分析,并采用名义组法原则,汇总分析结果为24条推荐意见和共识建议。进一步明确复方金钱草颗粒治疗泌尿系结石和尿路感染的适应症、用法用药、疗程、介入时间、联合用药等,说明了临床应用的安全性,并分别进行30以上的专家组进行了征求意见和同行评议。本共识旨在指导临床正确使用复方金钱草颗粒治疗泌尿系结石和尿路感染。 Compound Jinqiancao Granules(复方金钱草颗粒)is a Class B Chinese patent medicine in the National Medical Insurance catalog,which is widely used in clinical practice for urinary calculi and urinary tract infection.After more than 40 years of clinical observation and long-term treatment and collaborative treatment,based on questionnaire survey,expert interviews and systematic analysis of research literature,it is considered that Compound Jinqiancao Granules has curative effects on urinary cal-culi and urinary tract infection,and are included in the guideline for recommended drug use.The consensus was developed in strict accordance with the expert consensus procedure of clinical application of proprietary Chinese medicine,and was formulated for the treatment of urinary calculi and urinary tract infection.The application experience of clinicians was collected in the form of questionnaires.On this basis,24 recommendations and consensus suggestions were finally obtained through comprehensive analy-sis of evidence-based medical evidence and the strategy of nominal group method.The indications,usage,course of treatment,intervention time and combined use of Compound Jinqiancao Granules in the treatment of urinary calculi and urinary tract infec-tion were put forward,and the safety of clinical application was explained,and the opinions and peer review were carried out by more than 30 expert groups.The purpose of this consensus is to guide the correct use of Compound Jinqiancao Granules in the treatment of urinary calculi and urinary tract infection.
作者 苏鑫鑫 高瞻 席俊羽 刘亚芬 丁家森 黎元元 谢雁鸣 Representative Writing and Formuating Group SU Xinxin;GAO Zhan;XI Junyu;LIU Yanfen;DING Jiasen;LI Yuanyuan;XIE Yanming;Representative Writing and Formuating Group(Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China;Academy of Traditional Chinese Medicine,Changchun 130021,Jilin,China;不详)
出处 《中华中医药学刊》 CAS 北大核心 2024年第6期252-258,共7页 Chinese Archives of Traditional Chinese Medicine
基金 中国民族医药学会“民族医药经典名方筛选和大品种培育研究”项目(020ZY378-130101) 中国中医科学院科技创新工程中医临床基础学科创新团队项目(CI2021B003)。
关键词 复方金钱草颗粒 泌尿系结石 尿路感染 专家共识 GRADE Compound Jinqiancao Granules(复方金钱草颗粒) urinary calculi urinary tract infection expert consensus GRADE
  • 相关文献

参考文献31

二级参考文献258

共引文献542

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部